BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33998267)

  • 1. Leishmanial apolipoprotein A-I expression: a possible strategy used by the parasite to evade the host's immune response.
    Kalantar K; Manzano-Román R; Ghani E; Mansouri R; Hatam G; Nguewa P; Rashidi S
    Future Microbiol; 2021 May; 16():607-613. PubMed ID: 33998267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Trypanosome Lytic Factor and innate immune cells in the resolution of cutaneous Leishmania infection.
    Pant J; Samanovic M; Nelson MT; Keceli MK; Verdi J; Beverley SM; Raper J
    PLoS Pathog; 2021 Sep; 17(9):e1008768. PubMed ID: 34559857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.
    Samanovic M; Molina-Portela MP; Chessler AD; Burleigh BA; Raper J
    PLoS Pathog; 2009 Jan; 5(1):e1000276. PubMed ID: 19165337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of trypanosome lytic factor: a novel component of innate immunity.
    Thomson R; Samanovic M; Raper J
    Future Microbiol; 2009 Sep; 4(7):789-96. PubMed ID: 19722834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to master the host immune system? Leishmania parasites have the solutions!
    Rossi M; Fasel N
    Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are neutrophils important host cells for Leishmania parasites?
    Ritter U; Frischknecht F; van Zandbergen G
    Trends Parasitol; 2009 Nov; 25(11):505-10. PubMed ID: 19762280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes.
    Thomson R; Molina-Portela P; Mott H; Carrington M; Raper J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19509-14. PubMed ID: 19858474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ; Olivier M
    Parasitology; 2005; 130 Suppl():S27-35. PubMed ID: 16281989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interface between the Leishmania-infected macrophage and the host's immune system.
    Russell DG; Medina-Acosta E; Golubev A
    Behring Inst Mitt; 1991 Feb; (88):68-79. PubMed ID: 2049048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parasitic evasion mechanisms: Leishmania as an example].
    Solbach W; Bogdan C; Moll H; Lohoff M; Röllinghoff M
    Immun Infekt; 1989 Aug; 17(4):129-40. PubMed ID: 2673994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei.
    Kieft R; Stephens NA; Capewell P; MacLeod A; Hajduk SL
    Mol Biochem Parasitol; 2012 May; 183(1):8-14. PubMed ID: 22226682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania species-dependent functional duality of toll-like receptor 2.
    Jafarzadeh A; Nemati M; Sharifi I; Nair A; Shukla D; Chauhan P; Khorramdelazad H; Sarkar A; Saha B
    IUBMB Life; 2019 Nov; 71(11):1685-1700. PubMed ID: 31329370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response.
    Liu D; Uzonna JE
    Front Cell Infect Microbiol; 2012; 2():83. PubMed ID: 22919674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasomes and Leishmania: in good times or bad, in sickness or in health.
    Zamboni DS; Sacks DL
    Curr Opin Microbiol; 2019 Dec; 52():70-76. PubMed ID: 31229882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic-like Leishmania exploit the host's autophagy machinery to reduce T-cell-mediated parasite elimination.
    Crauwels P; Bohn R; Thomas M; Gottwalt S; Jäckel F; Krämer S; Bank E; Tenzer S; Walther P; Bastian M; van Zandbergen G
    Autophagy; 2015; 11(2):285-97. PubMed ID: 25801301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.
    Vellozo NS; Rigoni TS; Lopes MF
    Front Immunol; 2021; 12():704429. PubMed ID: 34249011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response to Leishmania: mechanisms of parasite control and evasion.
    Bogdan C; Röllinghoff M
    Int J Parasitol; 1998 Jan; 28(1):121-34. PubMed ID: 9504340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.
    Bullard W; Kieft R; Capewell P; Veitch NJ; Macleod A; Hajduk SL
    Virulence; 2012; 3(1):72-6. PubMed ID: 22286709
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.